Assay and medicament
US-2022325251-A1 · Oct 13, 2022 · US
Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered
Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C12N7/045 |
| Official title | {Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered} |
| Display label | Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered |
| Total patents | 78 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is growing.
| Year | Patents |
|---|---|
| 2015 | 5 |
| 2016 | 7 |
| 2017 | 9 |
| 2018 | 7 |
| 2019 | 7 |
| 2020 | 11 |
| 2021 | 2 |
| 2022 | 13 |
| 2023 | 2 |
| 2024 | 8 |
| 2025 | 4 |
| 2026 | 3 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
CPMV enhancer elements
US-11441150-B2 · Sep 13, 2022 · US
A porcine circovirus type 2 (pcv2) vaccine
US-2022265808-A1 · Aug 25, 2022 · US
Treatment method utilizing chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E2 and E1 structural proteins
US-11369674-B2 · Jun 28, 2022 · US
Assay and medicament
US-11339374-B2 · May 24, 2022 · US
Recombinant adenoviruses carrying transgenes
US-2022125946-A1 · Apr 28, 2022 · US
Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules
US-11305015-B2 · Apr 19, 2022 · US
Methods of detection and removal of rhabdoviruses from cell lines
US-11286282-B2 · Mar 29, 2022 · US
Promoters
US-11261464-B2 · Mar 1, 2022 · US
Host bacterium specific nanoparticle
US-2022056474-A1 · Feb 24, 2022 · US
Recombinant adenoviruses carrying transgenes
US-11253608-B2 · Feb 22, 2022 · US
Method for detecting protein-protein interactions in a cell utilizing particle-forming polypeptide-bait fusion proteins and virus-like particles
US-11237174-B2 · Feb 1, 2022 · US
Fusion protein
US-2021386850-A1 · Dec 16, 2021 · US
Plant produced porcine circovirus pseudovirion
US-2021277412-A1 · Sep 9, 2021 · US
Enhancing endonuclease based gene editing in primary cells
US-2020377911-A1 · Dec 3, 2020 · US
CPMV Enhancer Elements
US-2020283784-A1 · Sep 10, 2020 · US
Cytomegalovirus Vectors Eliciting T Cells Restricted By Major Histocompatibility Complex E Molecules
US-2020237915-A1 · Jul 30, 2020 · US
Assay and medicament
US-2020231939-A1 · Jul 23, 2020 · US
Methods of detection and removal of rhabdoviruses from cell lines
US-2020190146-A1 · Jun 18, 2020 · US
Stable cell lines for retroviral production
US-2020123505-A1 · Apr 23, 2020 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C12N7/045?
- CPC C12N7/045 is the Cooperative Patent Classification code for “Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered.”
- How many patents are filed under CPC C12N7/045 (Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered)?
- Our database includes 78 publications tagged with this CPC code.
- Is patent activity under CPC C12N7/045 growing?
- Publication counts under this code: 8 in 2024 vs 4 in 2025 (latest complete years).